Drug delivery and drug targeting with parenteral lipid nanoemulsions - A review

Journal of Controlled Release

Volumn 223, Issue , 2016, Pages 85-98

  Hörmann, Karl ^a   Zimmer, Andreas ^b  

^a Fresenius Kabi Austria GmbH   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Drug delivery system; Drug targeting; Emulsion; Ingredients; Intravenous; Manufacturing; Materials; Nanoemulsion; Parenteral

Indexed keywords

BIOCHEMISTRY; COMMERCE; DISPERSIONS; EMULSIFICATION; EMULSIONS; MANUFACTURE; MATERIALS;

DRUG DELIVERY SYSTEM; DRUG-TARGETING; INGREDIENTS; INTRAVENOUS; NANOEMULSION; PARENTERAL;

DROPS;

ALBUMIN; LIGAND; LIPID; SUGAR; SURFACTANT; EMULSION; MACROGOL DERIVATIVE; NANOPARTICLE; PROTEIN;

ADSORPTION; DRUG DELIVERY SYSTEM; DRUG TARGETING; HUMAN; MONONUCLEAR PHAGOCYTE; NANOEMULSION; OPSONIZATION; PARENTERAL NUTRITION; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SURFACE CHARGE; SURFACE PROPERTY; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; EMULSION; PARENTERAL DRUG ADMINISTRATION;

ANIMALS; DRUG DELIVERY SYSTEMS; EMULSIONS; HUMANS; INFUSIONS, PARENTERAL; LIPIDS; NANOPARTICLES; PARENTERAL NUTRITION; POLYETHYLENE GLYCOLS; PROTEINS; SURFACE PROPERTIES;

EID: 84952683451     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.12.016     Document Type: Review

References (82)

1. S. Mendes, S.R. Graziani, T.S. Vitório, A.F. Padoveze, R. Hegg, S.P. Bydlowski, and et al. Uptake by breast carcinoma of a lipidic nanoemulsion after intralesional injection into the patients: a new strategy for neoadjuvant chemotherapy Gynecol. Oncol. 112 2009 400 404 10.1016/j.ygyno.2008.10.018
2. M. Hashida, S. Kawakami, and F. Yamashita Lipid carrier systems for targeted drug and gene delivery Chem. Pharm. Bull. (Tokyo) 53 2005 871 880 10.1248/cpb.53.871
3. O. Suitthimeathegorn, J.A. Turton, H. Mizuuchi, and A.T. Florence Intramuscular absorption and biodistribution of dexamethasone from non-aqueous emulsions in the rat Int. J. Pharm. 331 2007 204 210 10.1016/j.ijpharm.2006.11.062
4. K. Hippalgaonkar, S. Majumdar, and V. Kansara Injectable lipid emulsions - advancements, opportunities and challenges AAPS PharmSciTech 11 2010 1526 1540 10.1208/s12249-010-9526-5
5. K.B. Sutradhar, and M.L. Amin Nanoemulsions: increasing possibilities in drug delivery Eur. J. Nanomedicine. 5 2013 97 110 10.1515/ejnm-2013-0001
6. A. Maali, and M.T.H. Mosavian Preparation and application of nanoemulsions in the last decade (2000-2010) J. Dispers. Sci. Technol. 34 2013 92 105 10.1080/01932691.2011.648498
7. S. Tamilvanan, S.R. Senthilkumar, R. Baskar, and T.R. Sekharan Manufacturing techniques and excipients used during the formulation of oil-in-water type nanosized emulsions for medical applications J. Excip. Food Chem. 1 2010 11 29
8. S. Tamilvanan Formulation of multifunctional oil-in-water nanosized emulsions for active and passive targeting of drugs to otherwise inaccessible internal organs of the human body Int. J. Pharm. 381 2009 62 76 10.1016/j.ijpharm.2009.08.001
9. A. Wretlind Development of fat emulsions JPEN J. Parenter. Enteral Nutr. 5 1981 230 235
10. A.G. Floyd Top ten considerations in the development of parenteral emulsions Pharm. Sci. Technol. Today 4 1999 134 143
11. F. Leal-Calderon, and M. Cansell The design of emulsions and their fate in the body following enteral and parenteral routes Soft Matter 8 2012 10213 10.1039/c2sm26215k
12. V. Klang, and C. Valenta Lecithin-based nanoemulsions J. Drug Deliv. Sci. Technol. 21 2011 55 76
13. S.M. Dordević, T.S. Radulović, N.D. Cekić, D.V. Randelović, M.M. Savić, D.R. Krajišnik, and et al. Experimental design in formulation of diazepam nanoemulsions: physicochemical and pharmacokinetic performances J. Pharm. Sci. 102 2013 4159 4172 10.1002/jps.23734
14. J. Rossi, and J.-C. Leroux Principles in the development of intravenous lipid emulsions K.M. Wasan, Role Lipid Excipients Modifying Oral Parenter 2007 Drug Deliv John Wiley & Sons, New York 88 123
15. Chylomicrons By Xvazquez (Own Work. [GFDL (http://www.gnu.org/copyleft/fdl.html), CC-BY-SA-3.0 or FAL], via Wikimedia Commons https://commons.wikimedia.org/wiki/File%3AChylomicron.svg 2008 (accessed July 23, 2015)
16. S. Tamilvanan Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems Prog. Lipid Res. 43 2004 489 533 10.1016/j.plipres.2004.09.001
17. M.N. Ton, C. Chang, Y.A. Carpentier, and R.J. Deckelbaum In vivo and in vitro properties of an intravenous lipid emulsion containing only medium chain and fish oil triglycerides Clin. Nutr. 24 2005 492 501 10.1016/j.clnu.2005.03.001
18. L. Liu, T.K. Hitchens, Q. Ye, Y. Wu, B. Barbe, D.E. Prior, and et al. Decreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with intralipid Biochim. Biophys. Acta 1830 2013 3447 3453 10.1016/j.bbagen.2013.01.021
19. M.A.J. Assink, P.E. Spronk, H.J.M. van Kan, and A. Braber Intravenous lipid emulsion in the treatment of verapamil intoxication Neth. J. Crit. Care 17 2013 18 21
20. M.R. Fettiplace, K. Lis, R. Ripper, K. Kowal, A. Pichurko, D. Vitello, and et al. Multi-modal contributions to detoxification of acute pharmacotoxicity by a triglyceride micro-emulsion J. Control. Release 198 2014 62 70 10.1016/j.jconrel.2014.11.018
21. K. Shi, Y. Xia, Q. Wang, Y. Wu, X. Dong, C. Chen, and et al. The effect of lipid emulsion on pharmacokinetics and tissue distribution of bupivacaine in rats Anesth. Analg. 116 2013 804 809 10.1213/ANE.0b013e318284123e
22. S. Ganta, M. Talekar, A. Singh, T.P. Coleman, and M.M. Amiji Nanoemulsions in translational research - opportunities and challenges in targeted cancer therapy AAPS PharmSciTech 2014 10.1208/s12249-014-0088-9
23. T. Takino, K. Konishi, Y. Takakura, and M. Hashida Long circulating emulsion carrier systems for highly lipophilic drugs Biol. Pharm. Bull. 17 1994 121 125
24. S. Ganta, J.W. Paxton, B.C. Baguley, and S. Garg Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion Int. J. Pharm. 360 2008 115 121 10.1016/j.ijpharm.2008.04.027
25. X. Li, L. Du, C. Wang, Y. Liu, X. Mei, and Y. Jin Highly efficient and lowly toxic docetaxel nanoemulsions for intravenous injection to animals Pharmazie 66 2011 479 483 10.1691/ph.2011.1015
26. D. Zhao, T. Gong, Y. Fu, Y. Nie, L.-L. He, J. Liu, and et al. Lyophilized cheliensisin A submicron emulsion for intravenous injection: characterization, in vitro and in vivo antitumor effect Int. J. Pharm. 357 2008 139 147 10.1016/j.ijpharm.2008.01.055
27. J. Li, S. Nie, X. Yang, C. Wang, S. Cui, and W. Pan Optimization of tocol emulsions for the intravenous delivery of clarithromycin Int. J. Pharm. 356 2008 282 290 10.1016/j.ijpharm.2007.12.046
28. S. Ramreddy, P. Kandadi, and K. Veerabrahma Formulation and pharmacokinetics of diclofenac lipid nanoemulsions for parenteral application PDA J. Pharm. Sci. Technol. 66 2012 28 37 10.5731/pdajpst.2012.00735
29. J. Zheng, Y. Tang, M. Sun, Y. Zhao, Q. Li, J. Zhou, and et al. Characterization, pharmacokinetics, tissue distribution and antitumor activity of honokiol submicron lipid emulsions in tumor-burdened mice Pharmazie 68 2013 41 46 10.1691/ph.2013.2062
30. A.M. Dierling, and Z. Cui Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy Int. J. Pharm. 303 2005 143 152 10.1016/j.ijpharm.2005.07.015
31. J.-H. Jang, C.-K. Kim, H.-G. Choi, and J.H. Sung Preparation and evaluation of 2-(allylthio)pyrazine-loaded lipid emulsion with enhanced stability and liver targeting Drug Dev. Ind. Pharm. 35 2009 363 368 10.1080/03639040802363696
32. B. Nikonenko, V.M. Reddy, E. Bogatcheva, M. Protopopova, L. Einck, and C.A. Nacy Therapeutic efficacy of SQ641-NE against Mycobacterium tuberculosis Antimicrob. Agents Chemother. 58 2014 587 589 10.1128/AAC.01254-13
33. A. Alayoubi, S. Kanthala, S.D. Satyanarayanajois, J.F. Anderson, P.W. Sylvester, and S. Nazzal Stability and in vitro antiproliferative activity of bioactive "Vitamin E" fortified parenteral lipid emulsions Colloids Surf. B: Biointerfaces 103 2013 23 30 10.1016/j.colsurfb.2012.10.003
34. A.Y. Alayoubi, J.F. Anderson, S.D. Satyanarayanajois, P.W. Sylvester, and S. Nazzal Concurrent delivery of tocotrienols and simvastatin by lipid nanoemulsions potentiates their antitumor activity against human mammary adenocarcenoma cells Eur. J. Pharm. Sci. 48 2012 385 392 10.1016/j.ejps.2012.12.011
35. C.L. Krahn, R.P. Raffin, G.S. Santos, L.B. Queiroga, R.L. Cavalcanti, P. Serpa, and et al. Isoflurane-loaded nanoemulsion prepared by high-pressure homogenization: investigation of stability and dose reduction in general anesthesia J. Biomed. Nanotechnol. 8 2012 849 858 10.1166/jbn.2012.1449
36. X. Chen, L. Zhang, X. Hu, X. Lin, Z. Yu, and X. Tang Formulation and preparation of a stable intravenous Disulfiram-loaded lipid emulsion Eur. J. Lipid Sci. Technol. 2014 10.1002/ejlt.201400278 (n/a-n/a)
37. M. Shawer, P. Greenspan, S. ØIe, and D.R. Lu VLDL-resembling phospholipid-submicron emulsion for cholesterol-based drug targeting J. Pharm. Sci. 91 2002 1405 1413 10.1002/jps.10117
38. T.C. Contente, I.F. Kretzer, F.B. Filippin-Monteiro, D.A. Maria, and R.C. Maranhão Association of daunorubicin to a lipid nanoemulsion that binds to low-density lipoprotein receptors enhances the antitumour action and decreases the toxicity of the drug in melanoma-bearing mice J. Pharm. Pharmacol. 66 2014 1698 1709 10.1111/jphp.12296
39. R.C. Maranhão, E.R. Tavares, A.F. Padoveze, C.J. Valduga, D.G. Rodrigues, and M.D. Pereira Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit Atherosclerosis 197 2008 959 966 10.1016/j.atherosclerosis.2007.12.051
40. M.L.N. Dias, J.P. Carvalho, D.G. Rodrigues, S.R. Graziani, and R.C. Maranhão Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers Cancer Chemother. Pharmacol. 59 2007 105 111 10.1007/s00280-006-0252-3
41. B. Madhusudhan, D. Rambhau, S.S. Apte, and D. Gopinath 1-O-alkylglycerol stabilized carbamazepine intravenous o/w nanoemulsions for drug targeting in mice J. Drug Target. 15 2007 154 161 10.1080/10611860601141150
42. C.-J. Wen, T.-C. Yen, S.A. Al-Suwayeh, H.-W. Chang, and J.-Y. Fang In vivo real-time fluorescence visualization and brain-targeting mechanisms of lipid nanocarriers with different fatty ester:oil ratios Nanomedicine (London) 6 2011 1545 1559 10.2217/nnm.11.46
43. L. Wei, G. Li, Y.-D. Yan, R. Pradhan, J.O. Kim, and Q. Quan Lipid emulsion as a drug delivery system for breviscapine: formulation development and optimization Arch. Pharm. Res. 35 2012 1037 1043 10.1007/s12272-012-0611-z
44. F. Xiong, H. Wang, Y.-J. Chen, K.-K. Geng, N. Gu, and J.-B. Zhu Characterization, biodistribution and targeting evaluation of breviscapine lipid emulsions following intravenous injection in mice Drug Deliv. 18 2011 159 165 10.3109/10717544.2010.528068
45. X. Zhang, X. Sun, J. Li, X. Zhang, T. Gong, and Z. Zhang Lipid nanoemulsions loaded with doxorubicin-oleic acid ionic complex: characterization, in vitro and in vivo studies Pharmazie 66 2011 496 505 10.1691/ph.2011.0379
46. K. Ogawara, Y. Yoshizawa, K. Un, T. Araki, and T. Kimura Challenges of Drug Delivery Systems That Contribute to Cancer Chemotherapy Nanoparticle-based Passive Drug Targeting to Tumors: Considerations and Implications for Optimization 36 2013 698 702
47. J. Seki, S. Sonoke, A. Saheki, H. Fukui, H. Sasaki, and T. Mayumi A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting Int. J. Pharm. 273 2004 75 83 10.1016/j.ijpharm.2003.12.022
48. K. Qi, M. Al-Haideri, T. Seo, Y.A. Carpentier, and R.J. Deckelbaum Effects of particle size on blood clearance and tissue uptake of lipid emulsions with different triglyceride compositions J. Parenter. Enter. Nutr. 27 2003 58 64
49. T. Onodera, I. Kuriyama, T. Andoh, H. Ichikawa, Y. Sakamoto, E. Lee-Hiraiwa, and et al. Influence of particle size on the in vitro and in vivo anti-inflammatory and anti-allergic activities of a curcumin lipid nanoemulsion Int. J. Mol. Med. 35 2015 1720 1728 10.3892/ijmm.2015.2186
50. F. Bruxel, S. Cojean, A. Bochot, H. Teixeira, C. Bories, P.-M. Loiseau, and et al. Cationic nanoemulsion as a delivery system for oligonucleotides targeting malarial topoisomerase II Int. J. Pharm. 416 2011 402 409 10.1016/j.ijpharm.2011.01.048
51. C.M. Keck, M. Jansch, and R.H. Müller Protein adsorption patterns and analysis on IV nanoemulsions - the key factor determining the organ distribution Pharmaceutics 5 2012 36 68 10.3390/pharmaceutics5010036
52. A. Torcello-Gómez, M. Wulff-Pérez, M.J. Gálvez-Ruiz, A. Martín-Rodríguez, M. Cabrerizo-Vílchez, and J. Maldonado-Valderrama Block copolymers at interfaces: interactions with physiological media Adv. Colloid Interf. Sci. 206 2014 414 427 10.1016/j.cis.2013.10.027
53. F.M. Veronese, and A. Mero The impact of PEGylation on biological therapies BioDrugs 22 2008 315 329 10.2165/00063030-200822050-00004
54. D.E. Owens, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 2006 93 102 10.1016/j.ijpharm.2005.10.010
55. F. Liu, and D. Liu Long-circulating emulsions (oil-in-water) as carriers for lipophilic drugs Pharm. Res. 12 1995 1060 1064 10.1023/A:1016274801930
56. A. Alayoubi, S. Alqahtani, A. Kaddoumi, and S. Nazzal Effect of PEG surface conformation on anticancer activity and blood circulation of nanoemulsions loaded with tocotrienol-rich fraction of palm oil AAPS J. 15 2013 1168 1179 10.1208/s12248-013-9525-z
57. D. Deshpande, D.R. Janero, and M. Amiji Engineering of an ω-3 polyunsaturated fatty acid-containing nanoemulsion system for combination C6-ceramide and 17β-estradiol delivery and bioactivity in human vascular endothelial and smooth muscle cells Nanomedicine 9 2013 885 894 10.1016/j.nano.2013.02.007
58. S. Ganta, P. Sharma, J.W. Paxton, B.C. Baguley, and S. Garg Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsion J. Drug Target. 18 2010 125 133 10.3109/10611860903244199
59. B.B. Lundberg, V. Risovic, M. Ramaswamy, and K.M. Wasan A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration J. Control. Release 86 2003 93 100 10.1016/S0168-3659(02)00323-1
60. Y. Yoshizawa, Y. Kono, K. Ogawara, T. Kimura, and K. Higaki PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy Int. J. Pharm. 412 2011 132 141 10.1016/j.ijpharm.2011.04.008
61. X. Jing, L. Deng, B. Gao, L. Xiao, Y. Zhang, X. Ke, and et al. A novel polyethylene glycol mediated lipid nanoemulsion as drug delivery carrier for paclitaxel Nanomedicine 10 2014 371 380 10.1016/j.nano.2013.07.018
62. H. Zhao, H. Lu, T. Gong, and Z. Zhang Nanoemulsion loaded with lycobetaine-oleic acid ionic complex: physicochemical characteristics, in vitro, in vivo evaluation, and antitumor activity Int. J. Nanomedicine 8 2013 1959 1973 10.2147/IJN.S43892
63. R.H. Müller Colloidal Carriers for Controlled Drug Delivery and Targeting: Modification, Characterization and In Vivo Distribution 1991 Taylor & Francis
64. J.M. Morachis, E.A. Mahmoud, and A. Almutairi Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles Pharmacol. Rev. 64 2012 505 519 10.1124/pr.111.005363
65. H. Zhou, J. Zhang, Q. Jin, G. Liu, Y. Long, M. Duan, and et al. Targeting of coenzyme Q10 via d-alpha-tocopheryl polyethylene glycol 1000 succinate-based nanoemulsion to the heart Mater. Lett. 109 2013 20 22 10.1016/j.matlet.2013.07.057
66. S. Raha, T. Paunesku, and G. Woloschak Peptide-mediated cancer targeting of nanoconjugates Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 3 2011 269 281 10.1002/wnan.121
67. P.A. Jarzyna, T. Skajaa, A. Gianella, D.P. Cormode, D.D. Samber, S.D. Dickson, and et al. Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging Biomaterials 30 2009 6947 6954 10.1016/j.biomaterials.2009.09.004
68. A. Gianella, P.A. Jarzyna, V. Mani, S. Ramachandran, C. Calcagno, J. Tang, and et al. Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer ACS Nano 5 2011 4422 4433 10.1021/nn103336a
69. S. Hak, E. Helgesen, H.H. Hektoen, E.M. Huuse, P.A. Jarzyna, W.J.M. Mulder, and et al. The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging ACS Nano 6 2012 5648 5658 10.1021/nn301630n
70. X. Zhang, H. Eden, and X. Chen Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates J. Control. Release 159 2012 2 13 10.1016/j.jconrel.2011.10.023.Peptides
71. D. Deshpande, S. Kethireddy, F. Gattacceca, and M. Amiji Comparative pharmacokinetics and tissue distribution analysis of systemically administered 17-β-estradiol and its metabolites in vivo delivered using a cationic nanoemulsion or a peptide-modified nanoemulsion system for targeting atherosclerosis J. Control. Release 180 2014 117 124 10.1016/j.jconrel.2014.02.009
72. B.B. Lundberg, G. Griffiths, and H.J. Hansen Conjugation of an anti-B-cell lymphoma monoclonal antibody, LL2, to long-circulating drug-carrier lipid emulsions J. Pharm. Pharmacol. 51 1999 1099 1105 10.1211/0022357991776787
73. D. Goldstein, T. Nassar, G. Lambert, J. Kadouche, and S. Benita The design and evaluation of a novel targeted drug delivery system using cationic emulsion-antibody conjugates J. Control. Release 108 2005 418 432 10.1016/j.jconrel.2005.08.021
74. D. Goldstein, O. Gofrit, A. Nyska, and S. Benita Anti-HER2 cationic immunoemulsion as a potential targeted drug delivery system for the treatment of prostate cancer Cancer Res. 67 2007 269 275 10.1158/0008-5472.CAN-06-2731
75. Y.K. Song, D. Liu, K. Maruyama, and T. Takizawa Antibody mediated lung targeting of long-circulating emulsions PDA J. Pharm. Sci. Technol. 50 1996 372 377
76. E. Ishida, C. Managit, S. Kawakami, M. Nishikawa, F. Yamashita, and M. Hashida Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice Pharm. Res. 21 2004 932 939 10.1023/B:PHAM.0000029280.39882.ff
77. W. Yeeprae, S. Kawakami, Y. Higuchi, F. Yamashita, and M. Hashida Biodistribution characteristics of mannosylated and fucosylated O/W emulsions in mice J. Drug Target. 13 2005 479 487 10.1080/10611860500293367
78. W. Yeeprae, S. Kawakami, F. Yamashita, and M. Hashida Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages J. Control. Release 114 2006 193 201 10.1016/j.jconrel.2006.04.010
79. P. Kandadi, M.A. Syed, S. Goparaboina, and K. Veerabrahma Albumin coupled lipid nanoemulsions of diclofenac for targeted delivery to inflammation Nanomedicine 8 2012 1162 1171 10.1016/j.nano.2011.12.006
80. J. D'Arrigo Stable Nanoemulsions: Self-assembly in Nature and Nanomedicine 2011 Elsevier 10.1016/B978-0-444-53798-0.00022-5
81. H.-C. Wu, and D.-K. Chang Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy J. Oncol. 2010 2010 723798 10.1155/2010/723798
82. Y. Zhao, J. Gao, X. Sun, H. Chen, L. Wu, and W. Liang Enhanced nuclear delivery and cytotoxic activity of hydro-xycamptothecin using o/w emulsions J. Pharm. Pharm. Sci. 10 2007 61 70